Cargando…

TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth

SIMPLE SUMMARY: Melanoma patients with liver metastasis have a poor prognosis, despite progress in therapeutic strategies. The cytokine Transforming Growth Factor β (TGF-β) plays a role in melanoma cells and acts on cells in the liver. We hypothesized that this cytokine influences the metastatic out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marvin, Dieuwke L., Dijkstra, Jelmer, Zulfiqar, Rabia M., Vermeulen, Michiel, ten Dijke, Peter, Ritsma, Laila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218053/ https://www.ncbi.nlm.nih.gov/pubmed/37240029 http://dx.doi.org/10.3390/ijms24108676

Ejemplares similares

TGF‐β signaling in liver metastasis
por: Marvin, Dieuwke L, et al.
Publicado: (2020)

Dynamic Visualization of TGF-β/SMAD3 Transcriptional Responses in Single Living Cells
por: Marvin, Dieuwke L., et al.
Publicado: (2022)

Low Transforming Growth Factor-β Pathway Activity in Cervical Adenocarcinomas
por: Marvin, Dieuwke L., et al.
Publicado: (2022)

TGFβ Signaling and Cardiovascular Diseases
por: Pardali, Evangelia, et al.
Publicado: (2012)

TGF-β in progression of liver disease
por: Dooley, Steven, et al.
Publicado: (2011)

Breast cancer dormancy is associated with a 4NG1 state and not senescence
por: Prunier, Chloé, et al.
Publicado: (2021)

Regulation of endothelial cell plasticity by TGF-β
por: van Meeteren, Laurens A., et al.
Publicado: (2011)

Targeting TGFβ signal transduction for cancer therapy
por: Liu, Sijia, et al.
Publicado: (2021)

TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
por: Drabsch, Yvette, et al.
Publicado: (2011)

TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling
por: Iyengar, Prasanna Vasudevan, et al.
Publicado: (2022)

Editorial: TGF-β and BMP signaling in cancer
por: Yan, Xiaohua, et al.
Publicado: (2022)

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
por: Hao, Yang, et al.
Publicado: (2019)

Key role for ubiquitin protein modification in TGFβ signal transduction
por: De Boeck, Miriam, et al.
Publicado: (2012)

Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
por: Suriyamurthy, Sudha, et al.
Publicado: (2019)

A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
por: Huynh, Linh Khanh, et al.
Publicado: (2019)

Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
por: Zhang, Jing, et al.
Publicado: (2020)

Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor
por: Kemaladewi, Dwi U, et al.
Publicado: (2014)

E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression
por: Sinha, Abhishek, et al.
Publicado: (2021)

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
por: Pardali, Evangelia, et al.
Publicado: (2017)

Age-dependent alteration of TGF-β signalling in osteoarthritis
por: van der Kraan, Peter M., et al.
Publicado: (2011)

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
por: Ma, Jin, et al.
Publicado: (2020)

Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial–mesenchymal transition of breast cancer cells
por: Zhang, Jing, et al.
Publicado: (2023)

TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
por: Hua, Wan, et al.
Publicado: (2019)

Integrin β1 activation induces an anti-melanoma host response
por: Ritsma, Laila, et al.
Publicado: (2017)

On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
por: Teixeira, Adilson Fonseca, et al.
Publicado: (2020)

The Role of TGF-β in Bone Metastases
por: Trivedi, Trupti, et al.
Publicado: (2021)

Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
por: van den Bulk, Jitske, et al.
Publicado: (2021)

Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma
por: Oria, Victor O., et al.
Publicado: (2022)

Statins attenuate outgrowth of breast cancer metastases
por: Beckwitt, Colin H., et al.
Publicado: (2018)

Metabolic Reprogramming of Mammary Epithelial Cells during TGF-β-Induced Epithelial-to-Mesenchymal Transition
por: Hua, Wan, et al.
Publicado: (2021)

Imaging the TGFβ type I receptor in pulmonary arterial hypertension
por: Rotteveel, Lonneke, et al.
Publicado: (2023)

Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
por: Sow, Heng Sheng, et al.
Publicado: (2019)

OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor
por: Fan, Chuannan, et al.
Publicado: (2022)

Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels
por: Ramnath, N. W. M., et al.
Publicado: (2015)

Focal adhesion kinase plays a dual role in TRAIL resistance and metastatic outgrowth of malignant melanoma
por: Del Mistro, Greta, et al.
Publicado: (2022)

Role of TGF-β in breast cancer bone metastases
por: Chiechi, Antonella, et al.
Publicado: (2013)

VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation
por: Li, Yihao, et al.
Publicado: (2019)

Cercosporamide inhibits bone morphogenetic protein receptor type I kinase activity in zebrafish
por: Hoeksma, Jelmer, et al.
Publicado: (2020)

Regulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signalling
por: Kurakula, Kondababu, et al.
Publicado: (2015)

Smad7 and protein phosphatase 1α are critical determinants in the duration of TGF-β/ALK1 signaling in endothelial cells
por: Valdimarsdottir, Gudrun, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_b65mhs36ri5go7bgcve09o7c0a